Skip to main content
Clinical Trials/ISRCTN27864936
ISRCTN27864936
Completed
Phase 4

A prospective randomised controlled trial assessing the efficacy of Pegatanib sodium (Macugen®) in the prevention of proliferative diabetic retinopathy

Frimley Park Hospital NHS Foundation Trust (UK)0 sites90 target enrollmentApril 29, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Frimley Park Hospital NHS Foundation Trust (UK)
Enrollment
90
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 29, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional

Investigators

Sponsor
Frimley Park Hospital NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Not provided at time of registration

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials